These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
427 related articles for article (PubMed ID: 29169725)
1. Ginsenoside Rg3 inhibits colorectal tumor growth via down-regulation of C/EBPβ/NF-κB signaling. Yang X; Zou J; Cai H; Huang X; Yang X; Guo D; Cao Y Biomed Pharmacother; 2017 Dec; 96():1240-1245. PubMed ID: 29169725 [TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Rg3 inhibits colorectal tumor growth through the down-regulation of Wnt/ß-catenin signaling. He BC; Gao JL; Luo X; Luo J; Shen J; Wang L; Zhou Q; Wang YT; Luu HH; Haydon RC; Wang CZ; Du W; Yuan CS; He TC; Zhang BQ Int J Oncol; 2011 Feb; 38(2):437-45. PubMed ID: 21152855 [TBL] [Abstract][Full Text] [Related]
3. Ginsenoside Rg3 promotes cytotoxicity of Paclitaxel through inhibiting NF-κB signaling and regulating Bax/Bcl-2 expression on triple-negative breast cancer. Yuan Z; Jiang H; Zhu X; Liu X; Li J Biomed Pharmacother; 2017 May; 89():227-232. PubMed ID: 28231544 [TBL] [Abstract][Full Text] [Related]
4. Ginsenoside Rg3 suppresses FUT4 expression through inhibiting NF-κB/p65 signaling pathway to promote melanoma cell death. Shan X; Tian LL; Zhang YM; Wang XQ; Yan Q; Liu JW Int J Oncol; 2015 Aug; 47(2):701-9. PubMed ID: 26094873 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of NF-kappaB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel. Kim SM; Lee SY; Yuk DY; Moon DC; Choi SS; Kim Y; Han SB; Oh KW; Hong JT Arch Pharm Res; 2009 May; 32(5):755-65. PubMed ID: 19471891 [TBL] [Abstract][Full Text] [Related]
6. Ginseng saponin metabolite 20(S)-protopanaxadiol inhibits tumor growth by targeting multiple cancer signaling pathways. Gao JL; Lv GY; He BC; Zhang BQ; Zhang H; Wang N; Wang CZ; Du W; Yuan CS; He TC Oncol Rep; 2013 Jul; 30(1):292-8. PubMed ID: 23633038 [TBL] [Abstract][Full Text] [Related]
7. Ginsenoside Rg3 sensitizes human non-small cell lung cancer cells to γ-radiation by targeting the nuclear factor-κB pathway. Wang L; Li X; Song YM; Wang B; Zhang FR; Yang R; Wang HQ; Zhang GJ Mol Med Rep; 2015 Jul; 12(1):609-14. PubMed ID: 25738799 [TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo. Tang YC; Zhang Y; Zhou J; Zhi Q; Wu MY; Gong FR; Shen M; Liu L; Tao M; Shen B; Gu DM; Yu J; Xu MD; Gao Y; Li W Int J Oncol; 2018 Jan; 52(1):127-138. PubMed ID: 29115601 [TBL] [Abstract][Full Text] [Related]
9. PC-SPES down-regulates COX-2 via inhibition of NF-kappaB and C/EBPbeta in non-small cell lung cancer cells. Ikezoe T; Yang Y; Saitoh T; Heber D; McKenna R; Taguchi H; Koeffler HP Int J Oncol; 2006 Aug; 29(2):453-61. PubMed ID: 16820889 [TBL] [Abstract][Full Text] [Related]
10. Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-kappaB. Kim SM; Lee SY; Cho JS; Son SM; Choi SS; Yun YP; Yoo HS; Yoon DY; Oh KW; Han SB; Hong JT Eur J Pharmacol; 2010 Apr; 631(1-3):1-9. PubMed ID: 20056115 [TBL] [Abstract][Full Text] [Related]
11. Asiaticoside suppresses cell proliferation by inhibiting the NF‑κB signaling pathway in colorectal cancer. Zhou X; Ke C; Lv Y; Ren C; Lin T; Dong F; Mi Y Int J Mol Med; 2020 Oct; 46(4):1525-1537. PubMed ID: 32945376 [TBL] [Abstract][Full Text] [Related]
12. Characterization of gene expression regulated by American ginseng and ginsenoside Rg3 in human colorectal cancer cells. Luo X; Wang CZ; Chen J; Song WX; Luo J; Tang N; He BC; Kang Q; Wang Y; Du W; He TC; Yuan CS Int J Oncol; 2008 May; 32(5):975-83. PubMed ID: 18425323 [TBL] [Abstract][Full Text] [Related]
13. Evodiamine Suppresses ABCG2 Mediated Drug Resistance by Inhibiting p50/p65 NF-κB Pathway in Colorectal Cancer. Sui H; Zhou LH; Zhang YL; Huang JP; Liu X; Ji Q; Fu XL; Wen HT; Chen ZS; Deng WL; Zhu HR; Li Q J Cell Biochem; 2016 Jun; 117(6):1471-81. PubMed ID: 26590365 [TBL] [Abstract][Full Text] [Related]
14. Ginsenoside Rg3 inhibits cell growth, migration and invasion in Caco-2 cells by downregulation of lncRNA CCAT1. Li J; Qi Y Exp Mol Pathol; 2019 Feb; 106():131-138. PubMed ID: 30633886 [TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Rg3 inhibits colon cancer cell migration by suppressing nuclear factor kappa B activity. Junmin S; Hongxiang L; Zhen L; Chao Y; Chaojie W J Tradit Chin Med; 2015 Aug; 35(4):440-4. PubMed ID: 26427115 [TBL] [Abstract][Full Text] [Related]
16. Ginsenoside Rb2 inhibits epithelial-mesenchymal transition of colorectal cancer cells by suppressing TGF-β/Smad signaling. Dai G; Sun B; Gong T; Pan Z; Meng Q; Ju W Phytomedicine; 2019 Mar; 56():126-135. PubMed ID: 30668333 [TBL] [Abstract][Full Text] [Related]
17. Ginsenoside Rg3 sensitizes hypoxic lung cancer cells to cisplatin via blocking of NF-κB mediated epithelial-mesenchymal transition and stemness. Wang J; Tian L; Khan MN; Zhang L; Chen Q; Zhao Y; Yan Q; Fu L; Liu J Cancer Lett; 2018 Feb; 415():73-85. PubMed ID: 29199005 [TBL] [Abstract][Full Text] [Related]
18. Ginsenoside Rg3 enhances the anti-proliferative activity of erlotinib in pancreatic cancer cell lines by downregulation of EGFR/PI3K/Akt signaling pathway. Jiang J; Yuan Z; Sun Y; Bu Y; Li W; Fei Z Biomed Pharmacother; 2017 Dec; 96():619-625. PubMed ID: 29035827 [TBL] [Abstract][Full Text] [Related]
19. Protective effects of ginsenoside Rg3 on TNF-α-induced human nucleus pulposus cells through inhibiting NF-κB signaling pathway. Chen J; Liu GZ; Sun Q; Zhang F; Liu CY; Yuan L; Zhao XQ; Wang YJ; Jia YS Life Sci; 2019 Jan; 216():1-9. PubMed ID: 30428306 [TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo anticancer effects of American ginseng berry: exploring representative compounds. Xie JT; Wang CZ; Zhang B; Mehendale SR; Li XL; Sun S; Han AH; Du W; He TC; Yuan CS Biol Pharm Bull; 2009 Sep; 32(9):1552-8. PubMed ID: 19721231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]